An NPR analysis of COVID-19 vaccination sites in major cities across the Southern U.S. reveals a racial disparity, with most sites located in whiter neighborhoods.
As wealthier countries horde doses, the Latin American nation is struggling to obtain an ample supply for its population while dealing with a daunting caseload.
Glitchy websites, jammed phone lines and long lines outside clinics are complicating the vaccine rollout. And older Americans and those without caregivers and computer skills are at a disadvantage.
Sudden demand flooded a county website and its phone lines. So CD Davidson-Hiers found herself in the middle of the chaos, fielding calls from residents eager to get vaccinated against COVID-19.
At least 70% of people will need to be immune from the coronavirus before COVID-19 can recede through a process known as herd immunity. Vaccines can play a role. But reaching the goal won't be easy.
The spread of new strains raises new questions as two COVID-19 vaccines continue their rollout across the U.S. and another vaccine candidate preps for regulatory review. Here's what you need to know.
The two companies producing COVID-19 vaccines for use in the United States will have to raise production to meet contractual goals of 100 million doses each by the end of March.
Dozens of protesters gathered at the entrance to one of the nation's largest mass-vaccination sites, leading officials to shut down the entrance for an hour.
City officials gave coronavirus vaccines to Philly Fighting Covid, whose brash CEO had no health care experience. After a WHYY investigation, the city cut ties with the group over alleged misconduct.
Large corporations such as Starbucks, Honeywell, Microsoft, Costco and Google want to help states with planning and logistics. But the potential of these partnerships is hindered by supply problems.
The state is a medical hub with giant hospitals and a huge healthcare workforce. Young adults who work in that field are getting the COVID-19 vaccine while at-risk seniors wait on the sidelines.
The vaccine did better at preventing disease in the U.S. – 72% — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.
Cadres of volunteers, mostly medical professionals, are part of a little-known federal emergency program launched in the aftermath of 9/11. Increasingly, states are deploying them against COVID-19.
The two countries are vying for a role in ending the pandemic by offering their vaccines to countries that can't afford or obtain other vaccines. But vaccine experts have a few concerns.
